Getinge informs about FDA Letter to Healthcare Providers related to Intra-Aortic Balloon Pumps
American Food & Drug Administration (FDA) has published today an updated reminder to health care providers related to previously communicated notifications connected to field corrections of Intra-Aortic Balloon Pumps.The updated reminder concerns devices running on AC power with only one battery, unexpected short battery runtime and fluid ingress. Customers have been previously informed according to the regular field correction process and information about the updated reminder can be found on FDAs website